Advanced search
Publication Cover
Leukemia & Lymphoma Volume 14, 1994 - Issue 3-4
Submit an article Journal homepage
13
Views
1
CrossRef citations to date
0
Altmetric
Original Article

A Phase II Study of Recombinant Granulocyte Macrophage Colony Stimulating Factor in Patients with Non-Hodgkin's Lymphoma

Tariq I. Mughal Departments of Medicine and Nursing, King Fahad National Guard Hospital, Riyadh, Saudi Arabia
&
Kathleen O'neill Departments of Medicine and Nursing, King Fahad National Guard Hospital, Riyadh, Saudi Arabia
Pages 331-334 | Received 23 Sep 1993, Published online: 01 Jul 2009

References

  • Frei E., III, Canellos G. P. Dose: A critical factor in cancer chemotherapy. Am. J. Med. 1980; 69: 585–594
  • Metcalf D. The granulocyte-macrophage colony-stimulating factor. Science 1985; 229: 16–22
  • Neidhart J., Magalik A., Kohler W., et al. Granulycote colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation. J. Clin. Oncol. 1989; 7: 1685–1692
  • Devries E. C., Biesma B., Willemse P. H., et al. A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma. Cancer Res. 1991; 51: 116–122
  • Vadhan-Raj S., Broxmeyer He., Hittelman W. N., et al. Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: Protection at the progenitor cell level. J. Clin. Oncol. 1992; 10: 1266–1277
  • De Vita V. T. Dose: Response is alive and well. J. Clin. Oncol. 1986; 4: 1157–1159
  • Kaplan L. D., Khan J. O., Crove S., et al. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: Results of a randomized trial. J. Clin. Oncol. 1991; 9: 929–940
  • Kantarjian H. M., Talpaz M., Kontoyiannis D., et al. Intensive chemotherapy in chronic myelogenous leukaemia (CML) in advanced phases with daunorubicin, high dose cytarabine and granulocyte-macrophage colony stimulating factor. J. Clin. Oncol. 1992; 10: 398–405
  • Amman K. S., Griffin J. D., Elias A., et al. Effect of recombinant number granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N. Engl. J. Med. 1988; 319: 593–598

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.